Curr Opin Pharmacol. 2002 Aug;2(4):361-5.

'Omic' and hypothesis-driven research in the molecular pharmacology of cancer.

Source

Genomics & Bioinformatics Group, Laboratory of Molecular Pharmacology, US National Cancer Institute, Building 37 Room 5068, National Institutes of Health, 9000 Rockville Pike, Bethesda, Maryland 20892, USA. jw4i@nih.gov

Abstract

Given the layered, evolutionary complexity of biological systems, it will not be possible to understand them comprehensively on the basis of hypothesis-driven research alone. Likewise, it will not be possible to do so solely through 'omic' studies of genes, proteins and other molecules in aggregate. The two modes of research are complementary and synergistic. The twin complexities of cancer biology and drug discovery demand such synergy as a basis for the next generation of oncopharmacomic research.

PMID:: 12127867; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms

Publication Types

Review

MeSH Terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Libraries

LinkOut Holdings

Supplemental Content

Related citations

Review Systems biology in drug discovery. [Nat Biotechnol. 2004]
Review Systems biology in drug discovery.
Butcher EC, Berg EL, Kunkel EJ. Nat Biotechnol. 2004 Oct; 22(10):1253-9.
Review The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome. [BJOG. 2006]
Review The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome.
Romero R, Espinoza J, Gotsch F, Kusanovic JP, Friel LA, Erez O, Mazaki-Tovi S, Than NG, Hassan S, Tromp G. BJOG. 2006 Dec; 113 Suppl 3:118-35.
Review Searching for pharmacogenomic markers: the synergy between omic and hypothesis-driven research. [Dis Markers. 2001]
Review Searching for pharmacogenomic markers: the synergy between omic and hypothesis-driven research.
Weinstein JN. Dis Markers. 2001; 17(2):77-88.
The impact of systems approaches on biological problems in drug discovery. [Nat Biotechnol. 2004]
The impact of systems approaches on biological problems in drug discovery.
Hood L, Perlmutter RM. Nat Biotechnol. 2004 Oct; 22(10):1215-7.
Review Integrating 'omic' information: a bridge between genomics and systems biology. [Trends Genet. 2003]
Review Integrating 'omic' information: a bridge between genomics and systems biology.
Ge H, Walhout AJ, Vidal M. Trends Genet. 2003 Oct; 19(10):551-60.

See reviews... See all...

Cited by 6 PubMed Central articles

iCOD: an integrated clinical omics database based on the systems-pathology view of disease. [BMC Genomics. 2010]
iCOD: an integrated clinical omics database based on the systems-pathology view of disease.
Shimokawa K, Mogushi K, Shoji S, Hiraishi A, Ido K, Mizushima H, Tanaka H. BMC Genomics. 2010 Dec 2; 11 Suppl 4:S19. Epub 2010 Dec 2.
Biomedical ontologies in action: role in knowledge management, data integration and decision support. [Yearb Med Inform. 2008]
Biomedical ontologies in action: role in knowledge management, data integration and decision support.
Bodenreider O. Yearb Med Inform. 2008; :67-79.
AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. [BMC Bioinformatics. 2006]
AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies.
Major SM, Nishizuka S, Morita D, Rowland R, Sunshine M, Shankavaram U, Washburn F, Asin D, Kouros-Mehr H, Kane D, et al. BMC Bioinformatics. 2006 Apr 6; 7:192. Epub 2006 Apr 6.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

'Omic' and hypothesis-driven research in the molecular pharmacology of cancer.
'Omic' and hypothesis-driven research in the molecular pharmacology of cancer.
Curr Opin Pharmacol. 2002 Aug ;2(4):361-5.

PubMed
Factors influencing the identification of transcription factor binding sites by ...
Factors influencing the identification of transcription factor binding sites by cross-species comparison.
Genome Res. 2002 Oct ;12(10):1523-32.

PubMed
Alternative splicing of the Drosophila Dscam pre-mRNA is both temporally and spa...
Alternative splicing of the Drosophila Dscam pre-mRNA is both temporally and spatially regulated.
Genetics. 2001 Oct ;159(2):599-608.

PubMed
Transcriptome profiles for high-cell-density recombinant and wild-type Escherich...
Transcriptome profiles for high-cell-density recombinant and wild-type Escherichia coli.
Biotechnol Bioeng. 2005 Apr 20 ;90(2):127-53.

PubMed
MIPS Arabidopsis thaliana Database (MAtDB): an integrated biological knowledge r...
MIPS Arabidopsis thaliana Database (MAtDB): an integrated biological knowledge resource based on the first complete plant genome.
Nucleic Acids Res. 2002 Jan 1 ;30(1):91-3.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Display Settings:

Send to: